Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Intravital microscopy identifies selectins that regulate T cell traffic into allografts
Thomas R. Jones, … , Thomas C. Pearson, Christian P. Larsen
Thomas R. Jones, … , Thomas C. Pearson, Christian P. Larsen
Published December 1, 2003
Citation Information: J Clin Invest. 2003;112(11):1714-1723. https://doi.org/10.1172/JCI19391.
View: Text | PDF
Article Immunology

Intravital microscopy identifies selectins that regulate T cell traffic into allografts

  • Text
  • PDF
Abstract

T cell homing to sites of injury and inflammation is a critical step for adaptive immune responses. While much has been learned regarding T cell homing to lymphoid tissues, few studies have directly observed trafficking events during an effector response. In this study, we developed a model that uses intravital fluorescence videomicroscopy to determine the molecules critical to T cell rolling within skin allograft microvasculature during the effector phase of the rejection response. Additional studies were performed to quantify T cell infiltrates as rejection progressed. We found that P-selectin and E-selectin expressed on postcapillary venules play overlapping roles in the recruitment of activated T cells in a SCID reconstitution model of skin graft rejection and are important in T cell accumulation at the graft site. Surprisingly, we also found that naive T cells are recruited and accumulate via constitutive T cell L-selectin and upregulated L-selectin ligands on rejecting allograft vasculature. These data indicated that a specific retinue of molecules is upregulated during the rejection response, and they suggest potential future therapeutic targets.

Authors

Thomas R. Jones, Nozomu Shirasugi, Andrew B. Adams, Thomas C. Pearson, Christian P. Larsen

×

Figure 1

Options: View larger image (or click on image) Download as PowerPoint
Graft rejection leads to enhanced rolling and firm adhesion interactions...
Graft rejection leads to enhanced rolling and firm adhesion interactions. (a) Adhesive interactions of CFSE-labeled naive T cells were analyzed at four time points after T cell reconstitution in venules of 1-month-healed syngeneic B6 (squares) and BALB/c allogeneic (diamonds) skin grafts on B6 SCID recipients. Rolling increased significantly in allografts as rejection progressed, and it remained equivalent at all time points in syngeneic grafts. *P < 0.04. Data are mean ± SEM, representative of three experiments; n = 3 in each group. (b) At day 4 of rejection, all vessels clearly illuminated with HMW TRITC-conjugated dextran. (c) At day 5 of rejection, vascular damage and interrupted flow were evident, as many small vessels (<50 μm) failed to illuminate with TRITC-dextran in allografts. (d and e) CFSE-labeled, activated T cells were infused at day 0 or day 4 after T cell reconstitution in SCID recipients of syngrafts and allografts. Labeled cells demonstrated equivalent rolling (d) and adhesion (e) at day 0 after reconstitution in BALB/c allografts (white bars) and B6 syngrafts (black bars) but showed a dramatic increase in rolling and firm adhesion by day 4 in allografts. **P < 0.04, ***P < 0.03. Data are mean ± SEM; n = 3 in each group.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts